Family Support Tool Intervention for Critical Illness
(FST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve the experience for older adults who are critically ill in the ICU and their families. It tests a new family support intervention, the Multi-component Family Support Intervention, which includes scheduled family meetings and an online tool to help families understand the ICU environment and communicate better with the medical team. The goal is to make care more patient- and family-centered and to reduce stress for both patients and their surrogate decision-makers. This trial may suit critically ill patients who cannot make decisions themselves and have a high risk of severe health issues, as well as their family members who assist in medical decision-making. As an unphased trial, this study offers a unique opportunity to contribute to innovative care strategies that could significantly enhance patient and family experiences in the ICU.
Will I have to stop taking my current medications?
The trial protocol does not specify whether participants must stop taking their current medications.
What prior data suggests that this family support intervention is safe for critically ill patients and their families?
Research shows that supporting families in intensive care units (ICUs) can be beneficial. A review of studies found that nearly two-thirds of these efforts improved patient outcomes in adult ICUs. However, family members might also face mental health challenges. Studies indicate that 20-60% of family members could experience stress-related symptoms like anxiety or depression during or after their loved one's ICU stay.
These efforts aim to enhance communication and care quality, but they can also impact emotions. Despite this, the primary goal is to support both patients and their families, making the ICU experience more focused on their needs and preferences.12345Why are researchers excited about this trial?
Researchers are excited about the Multi-component Family Support Intervention for critical illness because it offers a holistic approach that goes beyond the usual ICU care. Unlike standard treatments that primarily focus on the medical needs of the patient, this intervention actively involves family members by providing tools and support to help them cope with their loved one's critical condition. The unique feature of this approach is its emphasis on improving communication and emotional support, potentially leading to better outcomes for both patients and their families. By addressing the emotional and informational needs of the family, this intervention could transform the way we manage critical illness in the ICU.
What evidence suggests that this multi-component family support intervention is effective for improving patient- and family-centeredness of care in critical illness?
Research shows that family support programs can be helpful in ICU settings. A review of studies found that about two-thirds of these programs improved patient outcomes. In this trial, participants in the intervention arm will receive the Multi-component Family Support Intervention, designed to help families understand the ICU and prepare for discussions with doctors. These programs aim to make care more patient- and family-focused, potentially reducing stress and improving decision-making. Meanwhile, the control arm will receive usual ICU care. In another study, a nurse-led family support program slightly increased family satisfaction.12356
Who Is on the Research Team?
Douglas B White, MD, MAS
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for critically ill older adults (age ≥60) in the ICU with a high risk of death or severe long-term impairment, and their family surrogates. Patients must lack decision-making capacity and have at least a 50% chance of dying or needing significant help with daily activities. Surrogates must be adults, speak English, able to use the internet, and not involved in conflicting studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Proactive family meetings within 48 hours of enrollment and every 5-7 days thereafter. Family members complete sections of an interactive web-based tool upon study enrollment, before family meetings, and any other time they wish.
Follow-up
Participants are monitored for patient and family-centeredness of care, functional status, and other outcomes at 3 and 6 months after hospital discharge.
What Are the Treatments Tested in This Trial?
Interventions
- Multi-component Family Support Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
University of North Carolina, Chapel Hill, NC, USA
Collaborator
VA Pittsburgh Healthcare System
Collaborator
Pittsburgh VA Medical Center-University Drive
Collaborator
Oregon Health and Science University
Collaborator
Baystate Medical Center
Collaborator
Duke University
Collaborator
New York City Health and Hospitals Corporation
Collaborator
University of North Carolina, Chapel Hill
Collaborator
National Institute on Aging (NIA)
Collaborator